SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
42 hedge funds and large institutions have $157M invested in Syros Pharmaceuticals, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 5 closing their positions.
Holders
42
Holders Change
+7
Holders Change %
+20%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
12
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
CC
1
Casdin Capital
New York
|
$2.22M |
2 |
RG
2
Redmile Group
San Francisco,
California
|
$11.5M |
3 |
3
Northern Trust
Chicago,
Illinois
|
$329K |
4 |
4
State Street
Boston,
Massachusetts
|
$554K |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$430K |